Kwality Pharmaceuticals Limited (BOM:539997)
India · Delayed Price · Currency is INR 3,590.75
+146.00 (4.24%)
At close: Aug 17, 2026
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 35.74 billion as of August 17, 2026. Its market cap has increased by 219.36% in one year.
Market Cap
35.74B
Enterprise Value
37.00B
Revenue
5.54B
Ranking
n/a
PE Ratio
44.10
Stock Price
3,590.75
ChartMarket Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 35.74B, an increase of 15,382.02%. That is a compound annual growth rate of 64.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 35.74B | 210.80% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi India | 74.77B |
| FDC Limited | 57.68B |
| Bliss GVS Pharma | 55.68B |
| Morepen Laboratories | 46.15B |
| Gufic Biosciences | 42.24B |
| Novartis India | 39.18B |
| Unichem Laboratories | 37.93B |
| Hikal | 26.87B |